Lidocaine Hci Injection, Solution
Product Images NDC 51662-1543

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Vial Labeling (51662 1543 1 Serialized Labeling)

Serialized Vial Labeling (51662 1543 1 Serialized Labeling)
This is a description for a medication package of Lidocaine HCI Injection. It is a preservative-free injection, contained in a 5mL single dose package. The package insert can be obtained from the manufacturer's distributor, HF Acquisition Co., LLC, located in Mukilteo, WA. The product's National Drug Code (NDC) is 55150-16545. Two other codes are also provided: CLC210067 and 237670394455. The other numbers are not relevant to the medication description.*
FDA Label Image

Vial Label (51662 1543 1 Vial Label)

Vial Label (51662 1543 1 Vial Label)
This is a prescription medicine with the National Drug Code 55150-165-05. It is sterile and can be resterilized by autoclaving. The medicine contains Lidocaine and should not be used if the solution is discolored or contains a precipitate. Any unused portion should be discarded. It is manufactured by Medtronic Pharma LLC, and is used for inflammation and nerve block. It can be used for caudal and epidural use, and is preservative-free. It comes in a single-dose vial of 5 mL.*
FDA Label Image

Case

FDA Label Image

Max Dosage (Max Dosage)

Max Dosage (Max Dosage)
The given text is a table indicating the recommended dosages for various types of anesthesia techniques such as Peripheral Nerve Blocks, Central Neural Blocks, and Sympathetic Nerve Blocks for different areas of the body like Brachial, Lumbar, and Cervical. The table highlights the recommended dosages in ml (milliliters) for each dermatome. Hence, this table can be useful for anesthesiologists, pain management physicians, surgeons, etc., for determining the recommended dosages for the different types of anesthesia techniques for different body areas.*
FDA Label Image

Pouch

FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This text provides a list of drugs associated with methemoglobinemia which is a condition where the blood cannot release oxygen properly to body tissues. The drugs are categorized based on their class and include nitrates/nitrites, local anesthetics, antineoplastics, antibiotics, anticonvulsants, and other drugs. Examples of drugs in these classes that can lead to methemoglobinemia are nitric oxide, nitroglycerin, benzocaine, nitrofurantoin, phenobarbitl, etc.*
FDA Label Image

Rfid

FDA Label Image

Structure (Structure)

FDA Label Image

Vial

Vial
This is a prescription drug called Rxonly. The product has a National Drug Code of 55150-165-05 and is sterile. It can be resterilized by autoclaving. It contains Lidocaine Hydrochloride Injection, USP and is intended for infiltration and nerve block, including Caudal and Epidural use. The product comes in a single dose vial size of 5mL without any preservatives. It warns the user not to use if the solution is discolored or contains a precipitate, and any unused portion should be discarded. The manufacturer is labeled as Medics Pharma LLC, based in E. Windsor, NJ. The product should be stored at 20° to 25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.